Allworth Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Allworth Financial’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$578	Hold	5	–	–	﹤0.01%	4825
2026 Q1	$549	Hold	5	–	–	﹤0.01%	4715
2025 Q4	$546	Hold	5	–	–	﹤0.01%	4510
2025 Q3	$478	Sell	5 -380	-99%	-$33.3K	﹤0.01%	4444
2025 Q2	$33.9K	Buy	385 +36	+10%	+$3.12K	﹤0.01%	2182
2025 Q1	$30.1K	Hold	349	–	–	﹤0.01%	1827
2024 Q4	$30K	Hold	349	–	–	﹤0.01%	1846
2024 Q3	$33.2K	Hold	349	–	–	﹤0.01%	1595
2024 Q2	$32.1K	Hold	349	–	–	﹤0.01%	1586
2024 Q1	$31.7K	Hold	349	–	–	﹤0.01%	1510
2023 Q4	$28.4K	Buy	+349	New	+$27.4K	﹤0.01%	1443
2023 Q3	–	Sell	-74	Closed	-$5.83K	–	3524
2023 Q2	$5.83K	Buy	+74	New	+$5.79K	﹤0.01%	2041

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Allworth Financial's PPH Position: Q2 2026 in Review

Allworth Financial held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 5 shares worth $578. The position accounts for ﹤0.01% of the portfolio, ranked #4825.

Allworth Financial first reported a position in PPH in Q2 2023 and has held it in 12 quarters since. The position peaked at $33.9K in Q2 2025. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Allworth Financial held 5 shares of VanEck Pharmaceutical ETF worth $578 as of Q2 2026.
Allworth Financial left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4825 holding.
Allworth Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and has held it in 12 quarters since.
Allworth Financial's VanEck Pharmaceutical ETF position peaked at $33.9K in Q2 2025.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.